Former President Donald Trump’s return to the White House is certain to bring about changes across many facets of the healthcare sector — including reproductive care, federal insurance ...

Maternal mental health conditions are among the most prevalent complications during pregnancy and the postpartum period. There is also a significant economic burden associated with maternal mental ...

Tech giant Microsoft has pursued dozens of partnerships with health systems over the past few years, with these focusing mainly on fine-tuning AI models to better serve busy clinicians. Last month ...

From L-R: Betty Pio, partner at Kearney; Dr. Rekha Kumar, chief medical officer at Found and practicing endocrinologist at New York-Presbyterian; Sheila Shah, managing director, L.E.K. Consulting ...

An AbbVie schizophrenia drug acquired as part of a multi-billion dollar deal has failed two mid-stage studies, dealing a setback to the company’s plans to compete with a Bristol Myers Squibb ...

Trust between patients and providers is the backbone of the healthcare industry, making it necessary for the healthcare workforce to reflect the breadth of backgrounds, races and creeds of the ...

Specialty medications are estimated to comprise 65% of drug spending by 2025, and health systems are rapidly addressing new industry demands with in-house programs to support high-cost, high-touch ...

Marissa Plescia is a reporter for MedCity News covering payers, employers and health tech. She previously worked at Becker’s Hospital Review as a finance reporter. Before that, she was a data ...

Ray Therapeutics’ gene therapy is independent of the causative genes driving inherited vision disorders, which CEO Paul Bresge says is important for reaching a broad patient population.